Abstract
Stimulation of CD28 alone has been shown to regulate cytokine gene transcription and expression of the type 1 insulin-like growth factor receptor (IGF-1R) in lymphocytes. In this study, the ephrin receptor tyrosine kinase ephA3, was identified as a new CD28-responsive gene in Jurkat cells by using a human cytokine/receptor array. EphA3 was not detected in normal peripheral T cells, in any subset of thymus-derived developing T cells, or in Hodgkin's lymphoma. However, contrary to previous findings, EphA3 was detected in a panel of T-cell lymphomas. Stimulation of Jurkat cells with ephrin-A5 resulted in loss of cell adhesion to fibronectin and recruitment of the adapter protein CrkII to EphA3. Interestingly, EphA3 expression in CD28-stimulated Jurkat cells was enhanced by IGF-1 or by overexpression of the IGF-1R, and was suppressed by anti-IGF-1R blocking antibodies. The data suggest that CD28- and IGF-1-regulated expression of EphA3 is associated with adherence and that it may be involved in the motility of malignant T cells.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies / pharmacology
-
CD28 Antigens / metabolism*
-
CD28 Antigens / pharmacology
-
Cell Adhesion / drug effects
-
Cell Adhesion / genetics
-
Cell Movement / drug effects
-
Cell Movement / genetics*
-
Ephrin-A5 / metabolism
-
Ephrin-A5 / pharmacology
-
Fibronectins / metabolism
-
Gene Expression Regulation / genetics
-
Gene Expression Regulation, Neoplastic / drug effects
-
Gene Expression Regulation, Neoplastic / genetics
-
Humans
-
Insulin-Like Growth Factor I / genetics
-
Insulin-Like Growth Factor I / metabolism*
-
Insulin-Like Growth Factor I / pharmacology
-
Jurkat Cells
-
Lymphoma, T-Cell / genetics
-
Lymphoma, T-Cell / metabolism*
-
Neoplasm Metastasis / genetics*
-
Proto-Oncogene Proteins / metabolism
-
Proto-Oncogene Proteins c-crk
-
Reaction Time / drug effects
-
Reaction Time / genetics
-
Receptor, EphA3 / metabolism*
-
Receptor, IGF Type 1 / antagonists & inhibitors
-
Receptor, IGF Type 1 / metabolism
-
Up-Regulation / drug effects
-
Up-Regulation / genetics
Substances
-
Antibodies
-
CD28 Antigens
-
Ephrin-A5
-
Fibronectins
-
Proto-Oncogene Proteins
-
Proto-Oncogene Proteins c-crk
-
Insulin-Like Growth Factor I
-
Receptor, EphA3
-
Receptor, IGF Type 1